Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference
September 19 2017 - 4:05PM
Novavax, Inc., (Nasdaq:NVAX) today announced the Company will
present at the Ladenburg Thalmann 2017 Healthcare Conference.
Presentation details are as follows:
Date: Tuesday, September 26, 2017Time: 11:00 –
11:25 am ETLocation: Track 5, Montmartre, Sofitel Hotel, New York
CityLive webcast: www.novavax.com, “Investors”/“Events”
A replay of the presentation will also be
accessible under the “Investors/Events” section of the Novavax
website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
biotechnology company committed to delivering novel products to
prevent a broad range of infectious diseases. Our recombinant
nanoparticles and Matrix-M™ adjuvant technology are the foundation
for groundbreaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax
is available on the Company's website, novavax.com.
Contact:
Investor RelationsNovavax, Inc.Andrea N. Flynn, Ph.D.Director,
Investor & Media
Relationsir@novavax.com240-268-2000
Westwicke PartnersJohn
Woolfordjohn.woolford@westwicke.com443-213-0506
MediaRusso Partners, LLCDavid SchullMaggie
Bellerdavid.schull@russopartnersllc.com
maggie.beller@russopartnersllc.com212-845-4271
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2024 to May 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From May 2023 to May 2024